An objective means for quantifying the myocardial mass supplied by each potential arterial target could optimize long-term survival in coronary bypass surgery, a large cohort study suggests.
Findings of equivalence in the largest-ever comparison of CABG and PCI for left main disease must be tempered by an understanding of study design limits and secondary outcomes, two cardiac surgeons contend.
Limited surgeon experience with bilateral ITA grafting was associated with poorer outcomes with the procedure. An expert explains why this argues for designating CABG a cardiac surgery subspecialty.
The new RADIAL analysis boosts support for the radial artery over the saphenous vein as a second conduit, but resistance to multiarterial grafting lingers. Two newer trials may help shift practice.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cardiac surgeon Faisal Bakaeen reflects on modern CABG’s impact over the past five decades — and how Dr. René Favaloro (pictured) was indispensable to its development.
The DACAB trial made headlines at AHA 2017, but it’s not likely to impact practice very much. Cardiac surgeon Faisal Bakaeen, MD, explains why.
The trial’s new health status analysis gives even more reason to consider CABG the preferred revascularization strategy for patients with anatomically complex three-vessel or left main disease.
Cleveland Clinic’s offering cardiovascular-oriented live CME for just about every subspecialty interest in the coming year. And not just in Cleveland.
The first guidelines specific to graft choice in CABG come 30 years after the seminal paper that established the internal thoracic artery as the gold standard. Here’s an overview of key new recommendations.
No one said choosing the best conduit for bypass surgery was easy. But this primer from a Cleveland Clinic cardiac surgeon sorts through the options to arrive at a few helpful guiding principles.